Publications in collaboration with researchers from Hospital Universitario Virgen del Rocío (21)

2024

  1. Clinical guideline on adequacy and prescription of peritoneal dialysis

    Nefrologia, Vol. 44, pp. 1-29

  2. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  3. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  4. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary

  5. Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study

    Frontiers in Endocrinology, Vol. 15

  6. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain

    Neuroendocrinology, Vol. 111, Núm. 10, pp. 925-936

  2. The SEEN comprehensive clinical survey of adult obesity: Executive summary

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 130-136

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

  2. Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly

    Endocrine, Vol. 70, Núm. 3, pp. 575-583

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

  2. Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study

    Pituitary, Vol. 22, Núm. 2, pp. 137-145

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2016

  1. Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 8, pp. 397-408

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. Maternal and Perinatal Outcomes After Bariatric Surgery: a Spanish Multicenter Study

    Obesity Surgery, Vol. 25, Núm. 3, pp. 436-442

2013

  1. Weight-related quality of life in spanish obese subjects suitable for bariatric surgery is lower than in their north american counterparts: A case-control study

    Obesity Surgery, Vol. 23, Núm. 4, pp. 509-514

2002

  1. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome

    Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749

1999

  1. Regulation of growth hormone secretion by signals produced by the adipose tissue

    Journal of Endocrinological Investigation, Vol. 22, Núm. 5 SUPPL., pp. 22-26